Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Guidnce

Allscripts (NASDAQ: MDRX) reported Q4 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $429.4 million versus the consensus estimate of $424.11 million.

2017 Financial Outlook

Allscripts affirms the following financial outlook for 2017, published originally on January 9, 2017:

• Non-GAAP revenue of between $1.71 billion and $1.74 billion;
• Adjusted EBITDA of between $345 million and $365 million, consisting of:
• Allscripts, excluding Netsmart, Adjusted EBITDA between $255-265 million, and;
• Netsmart Adjusted EBITDA between $90-100 million
• Non-GAAP earnings per share growth of between 10 to 15 percent

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Playboy to buy back 16.6M shares from Fortress at $1.05 each